Pavadi Capital’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$6.76M Buy
85,580
+29,562
+53% +$2.1M 8.32% 6
2023
Q3
$3.91M Sell
56,018
-6,900
-11% -$489K 5.09% 11
2023
Q2
$4.35M Sell
62,918
-2,250
-3% -$160K 5.07% 14
2023
Q1
$4.84M Buy
65,168
+3,728
+6% +$313K 5.29% 11
2022
Q4
$5.73M Buy
61,440
+13,899
+29% +$1.34M 5.4% 10
2022
Q3
$4.53M Sell
47,541
-4,592
-9% -$455K 4.34% 8
2022
Q2
$4.83M Buy
52,133
+8,302
+19% +$810K 4.38% 11
2022
Q1
$4.44M Sell
43,831
-6,738
-13% -$708K 3.91% 12
2021
Q4
$5.22M Buy
+50,569
New +$4.67M 3.96% 15

Other funds holding CVS

Pavadi Capital's CVS Position: Q4 2023 in Review

Pavadi Capital increased its CVS Health (CVS) stake by 53% in Q4 2023, buying an estimated $2.1M and bringing the position to 85,580 shares worth $6.76M. The position accounts for 8.32% of the portfolio, ranked #6.

Pavadi Capital first reported a position in CVS in Q4 2021 and has held it in 9 quarters since. 2,258 funds tracked by Wall St. Rank hold CVS as of Q4 2023.

  • Pavadi Capital held 85,580 shares of CVS Health worth $6.76M as of Q4 2023.
  • Pavadi Capital bought 29,562 CVS Health shares in Q4 2023, an estimated $2.1M.
  • CVS Health made up 8.32% of Pavadi Capital's portfolio in Q4 2023, its #6 holding.
  • Pavadi Capital first reported a position in CVS Health in Q4 2021 and has held it in 9 quarters since.
  • 2,258 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.

Based on Pavadi Capital's 13F filing for Q4 2023, filed 14 Feb 2024.